Stay updated with breaking news from Bruce Keyt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pale Fire Capital SE bought a new stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,601 shares of the company’s stock, valued at approximately $105,000. Several other hedge funds and […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 4,670,000 shares, a growth of 7.9% from the December 15th total of 4,330,000 shares. Based on an average daily volume of 355,100 shares, […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) shot up 7.1% during trading on Thursday . The company traded as high as $8.97 and last traded at $8.93. 32,757 shares traded hands during trading, a decline of 88% from the average session volume of 279,517 shares. The stock had previously closed at $8.34. Analyst Ratings […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) insider Bruce Keyt sold 7,574 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $5.78, for a total transaction of $43,777.72. Following the completion of the transaction, the insider now directly owns 129,551 […]
Operator: Good day, everyone, and welcome to the IGM Biosciences' Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. Today's call is being recorded.